Arana Therapeutics (Acquired by Cephalon)
Press releases archived for reference only.
19 - 25 Khartoum Road
Macquarie Park
New South Wales
2113
38 articles about Arana Therapeutics (Acquired by Cephalon)
-
Arana Therapeutics To Present At Piper Jaffray Healthcare Conference And Bank of America Merrill Lynch Animal Health Summit
11/23/2015
-
Arana Therapeutics to Report Second Quarter 2013 Financial Results
7/23/2013
-
Arana Therapeutics Expands Senior Management Team with Appointment of Julia A. Stephanus as Chief Commercial Officer
1/15/2013
-
Cephalon, Inc. Completes Acquisition of Arana Therapeutics, Acquisition Diversifies Cephalon Technology Portfolio and Forms Foundation for Biologics Business
8/11/2009
-
Arana Therapeutics Board Changes
5/28/2009
-
Cephalon, Inc.Takeover Offer for Arana Therapeutics Declared Unconditional
5/21/2009
-
Cephalon, Inc. Acquires Controlling Interest in Arana Therapeutics
5/20/2009
-
Arana Therapeutics Provides Update On Status On Cephalon, Inc. Offer
5/6/2009
-
Arana Therapeutics Granted Patents in Australia
3/23/2009
-
Arana Therapeutics Successfully Completes Phase II Psoriasis Study; ART621 Meets Primary Endpoint
3/9/2009
-
Arana Therapeutics Release: Cancellation: Share Buyback; Announcement: 5 Cents Dividend
3/2/2009
-
Arana Therapeutics Non-Independent Director Resigns After Takeover Offer
3/2/2009
-
Cephalon, Inc. (JOBS) Subsidiary Launches US$207 Million Takeover Offer for Australia-based Arana Therapeutics (JOBS)
2/27/2009
-
Arana Therapeutics Announces Discontinuation Of PMX53 For Ocular Indications
2/19/2009
-
Arana Therapeutics Announces Issuance of Key European Patent for Evibodies
2/9/2009
-
Arana Therapeutics Commences International Phase II Trial In RA
12/11/2008
-
Arana Therapeutics Completes Second Project for GlaxoSmithKline
12/1/2008
-
Arana Therapeutics Commences ART621 Phase II Rheumatoid Arthritis Trial
11/26/2008
-
Arana Therapeutics Reports Increased Revenues and Strong Financial Position
11/13/2008
-
Arana Therapeutics Announces Appointment of Acting CEO
11/13/2008